医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Digital Transformation Will Boost Growth in the Healthcare IT Market in the APAC Region through 2019: Technavio

2015年04月07日 AM12:35
このエントリーをはてなブックマークに追加


 

LONDON

Technavio has published a new report on the Healthcare IT (HIT) Market in the APAC Region, which is expected to grow at a CAGR of 16 percent from 2015-2019.

About the Report

Healthcare providers need to store patient’s digital records and data for future reference, which is being made possible through digital transformation in the healthcare industry.

“To provide improved healthcare services and stay competitive in the market, healthcare providers need to extract information from stored patient data, which will lead to increased spending on healthcare BI and analytics solutions,” says Faisal Ghaus, Vice President of Technavio.

The latest report by Technavio also emphasizes telemedicine, which is one of the key areas that is gaining popularity in the APAC region.

“Telemedicine is the largest market in the Indian healthcare sector, and is expected to fill the gap between demand and supply in the healthcare sector in India. Most of the major hospitals in India have adopted telemedicine services and are entering into public–private partnerships,” says Ghaus.

Market Scope and Calculation of Market Size

The new Technavio report covers the present scenario and the growth prospects of the HIT Market in the APAC region from 2015-2019. To calculate the market size, the report considers revenue generated from clinical and non-clinical healthcare information systems.

Key Information Covered in the Report:

  • Key Vendors:

    • Accenture plc
    • athenahealth
    • Cerner Corp.
    • Fujitsu Ltd.
    • GE Healthcare
    • IBM Corp.
    • Philips Healthcare
  • Market Growth Drivers:
    • Increased Need for Digital Transformation
    • For a full detailed list, view our report.
  • Market Challenges:
  • Market Trends:

Technavio currently has more than 3000 market research reports on a huge range of topics, including 200+ reports on the healthcare market:

If you are interested in more information, please contact our media team at media@technavio.com.

CONTACT

Technavio Research
Jes Ellacott
Media & Marketing Executive
US:
+1 630-333-9501
UK: +44 208 123 1770
www.technavio.com
media@technavio.com

同じカテゴリーの記事 

  • LC-Plasma-based Vaccine Research Selected for SCARDA Project
  • 一份具有里程碑意义的报告证明,大量使用尼古丁不会导致健康问题高发
  • Modalis Therapeutics Reports Data Supporting Development of a Transformative Epigenome Editing Therapeutic, MDL-101: a First-in-Class Epigenome Editing approach for the Treatment of LAMA2-deficient congenital muscular dystrophy (LAMA2-CMD)
  • Galderma Receives Filing Acceptances for Nemolizumab in Prurigo Nodularis and Atopic Dermatitis in Four Additional Countries
  • Inocras Hong Kong Limited, in Collaboration with Cancerinformation.com.hk Charity Foundation and Sponsored by AstraZeneca Hong Kong, Offers Free BRCA or HRD Genetic Testing for Eligible Cancer Patients in Hong Kong and Macau